Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

2019612 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: The Lancet

Volume 394, Issue 10193, pp. 131-138

Field-Weighted Citation Impact: 51.07